Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement – MarketWatch (press release)
|
Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement
MarketWatch (press release) 24, 2012 /PRNewswire via COMTEX/ — Sinovac Biotech Ltd. /quotes/zigman/91613/quotes/nls/sva SVA 0.00% , a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. |
